NO20031923D0 - Ny behandling av "restless legs" syndrom - Google Patents

Ny behandling av "restless legs" syndrom

Info

Publication number
NO20031923D0
NO20031923D0 NO20031923A NO20031923A NO20031923D0 NO 20031923 D0 NO20031923 D0 NO 20031923D0 NO 20031923 A NO20031923 A NO 20031923A NO 20031923 A NO20031923 A NO 20031923A NO 20031923 D0 NO20031923 D0 NO 20031923D0
Authority
NO
Norway
Prior art keywords
syndrome
new treatment
restless legs
restless
legs
Prior art date
Application number
NO20031923A
Other languages
English (en)
Other versions
NO20031923L (no
Inventor
Sylvia S Mcbrinn
Richard W Anderson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20031923D0 publication Critical patent/NO20031923D0/no
Publication of NO20031923L publication Critical patent/NO20031923L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Fats And Perfumes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20031923A 2000-10-31 2003-04-29 Nye behandlinger for "restless legs"-syndromet NO20031923L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24466600P 2000-10-31 2000-10-31
PCT/US2001/027785 WO2002036123A2 (en) 2000-10-31 2001-10-29 New treatments for restless legs syndrome

Publications (2)

Publication Number Publication Date
NO20031923D0 true NO20031923D0 (no) 2003-04-29
NO20031923L NO20031923L (no) 2003-06-27

Family

ID=22923642

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031923A NO20031923L (no) 2000-10-31 2003-04-29 Nye behandlinger for "restless legs"-syndromet

Country Status (18)

Country Link
US (2) US6602868B2 (no)
EP (1) EP1330248A2 (no)
JP (1) JP2004512367A (no)
KR (1) KR20030042037A (no)
CN (1) CN1606442A (no)
AR (1) AR031152A1 (no)
AU (1) AU2002211226A1 (no)
BR (1) BR0115071A (no)
CA (1) CA2421705A1 (no)
EA (1) EA200300527A1 (no)
IL (1) IL155591A0 (no)
MX (1) MXPA03003912A (no)
NO (1) NO20031923L (no)
NZ (1) NZ525574A (no)
PE (1) PE20020514A1 (no)
PL (1) PL360904A1 (no)
WO (1) WO2002036123A2 (no)
ZA (1) ZA200301865B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2314893C (en) 1997-12-22 2005-09-13 Euro-Celtique, S.A. Opioid agonist/antagonist combinations
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
EP2425821B1 (en) 2002-04-05 2017-05-10 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
US20050079217A1 (en) * 2002-07-25 2005-04-14 Ganorkar Loksidh D. Sustained-release tablet composition comprising a dopamine receptor agonist
AU2003277296A1 (en) * 2002-10-04 2004-05-04 Pharmacia Corporation Compositions and methods for treating sexual dysfunction
AU2003267769A1 (en) * 2002-10-25 2004-05-13 Pharmacia & Upjohn Company Llc Use of heterocyclic amine-type compounds as neuroprotective agents
BRPI0414481A (pt) 2003-09-17 2006-11-14 Xenoport Inc métodos de tratamento ou de prevenção da sìndrome das pernas inquietas em um paciente e de melhoria do sono em um paciente com sìndrome das pernas inquietas, e, composição farmacêutica
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
MX2007009162A (es) * 2005-01-28 2007-10-23 Euro Celtique Sa Formas de dosis rsistente al alcohol.
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
JP2009501184A (ja) 2005-07-13 2009-01-15 エフ．ホフマン−ラ ロシュ アーゲー ５−ｈｔ６、５−ｈｔ２４としてのベンゾイミダゾール誘導体
US20100168119A1 (en) * 2008-11-05 2010-07-01 Pharmorx, Inc. Compositions and methods for minimizing or reducing agonist-induced desensitization
JP5886632B2 (ja) 2009-03-10 2016-03-16 ユーロ−セルティーク エス．エイ． オキシコドンおよびナロキソンを含む即時放出医薬組成物
US8690933B2 (en) * 2009-08-31 2014-04-08 Brigham Young University System and method for treating symptoms of restless legs syndrome
EP2618826B1 (en) * 2010-09-20 2016-04-13 A.Carlsson Research AB Phenylpiperidine compounds for the treatment of dementia
EP2950799B1 (en) 2013-01-30 2019-12-04 Pharmorx Therapeutics, Inc. Treatments for depression and other diseases with a low dose agent
KR20160034352A (ko) 2013-07-23 2016-03-29 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
EP3337497B1 (en) 2015-08-21 2023-07-12 SRX Cardio, LLC Composition and methods of use of novel phenylalanine small organic compounds to directly modulate pcsk9 protein activity
EP3337564A4 (en) 2015-08-21 2019-01-23 Portola Pharmaceuticals, Inc. COMPOSITION AND METHOD FOR THE USE OF TETRAHYDROISOCHINOLINE SMALL MOLECULES FOR THE BINDING AND MODULATION OF PCSK9 PROTEIN ACTIVITY
US10568882B2 (en) 2015-08-21 2020-02-25 Srx Cardio, Llc Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
WO2017147328A1 (en) 2016-02-23 2017-08-31 Portola Pharmaceuticals, Inc. Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
WO2021067751A1 (en) 2019-10-03 2021-04-08 Noctrix Health, Inc. Peripheral nerve stimulation for restless legs syndrome
JP7159169B2 (ja) 2017-01-05 2022-10-24 ノクトリックス ヘルス インコーポレイテッド レストレスレッグス症候群または過活動神経治療

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273975A (en) 1989-06-09 1993-12-28 The Upjohn Company Heterocyclic amines having central nervous system activity
ATE201669T1 (de) 1991-04-17 2001-06-15 Upjohn Co Substituierte (s)-3-phenylpiperidin derivate, deren herstellung und deren verwendung als dopamin autorezeptor antagonisten
AUPO274596A0 (en) * 1996-10-04 1996-10-31 Armstrong, Stuart Maxwell Method for the treatment of neurological or neuropsychiatric disorders
US6001861A (en) 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
US6197339B1 (en) 1997-09-30 2001-03-06 Pharmacia & Upjohn Company Sustained release tablet formulation to treat Parkinson's disease
EA002554B1 (ru) 1998-03-27 2002-06-27 Фармация Энд Апджон Компани Применение кабэрголина при лечении синдрома усталых ног
SE9802546D0 (sv) * 1998-07-15 1998-07-15 Ross Nicholas Waters Medicinal product and method for treatment and prevention of dyskinesia
US6455564B1 (en) 1999-01-06 2002-09-24 Pharmacia & Upjohn Company Method of treating sexual disturbances
DE19938823A1 (de) 1999-08-19 2001-02-22 Boehringer Ingelheim Pharma Medikamentöse Behandlung des Restless Leg Syndroms
US6448258B2 (en) * 2000-04-21 2002-09-10 Pharmacia & Upjohn Company Treating fibromyalgia and chronic fatigue syndrome
AR033520A1 (es) * 2000-04-27 2003-12-26 Upjohn Co (5r)-(metilamino) -5,6-dihidro-4h-imidazo[4,5,1-ij] quinolin-2(1h)-tiona

Also Published As

Publication number Publication date
KR20030042037A (ko) 2003-05-27
WO2002036123A2 (en) 2002-05-10
CA2421705A1 (en) 2002-05-10
AR031152A1 (es) 2003-09-10
IL155591A0 (en) 2003-11-23
CN1606442A (zh) 2005-04-13
JP2004512367A (ja) 2004-04-22
EP1330248A2 (en) 2003-07-30
PL360904A1 (en) 2004-09-20
BR0115071A (pt) 2003-07-29
US6716854B2 (en) 2004-04-06
EA200300527A1 (ru) 2003-08-28
AU2002211226A1 (en) 2002-05-15
US20030212065A1 (en) 2003-11-13
NO20031923L (no) 2003-06-27
NZ525574A (en) 2004-12-24
WO2002036123A3 (en) 2002-09-19
US6602868B2 (en) 2003-08-05
ZA200301865B (en) 2004-06-25
PE20020514A1 (es) 2002-06-12
MXPA03003912A (es) 2004-09-10
US20020107257A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
NO20031923D0 (no) Ny behandling av "restless legs" syndrom
DK1267650T3 (da) Tobakbehandling
NO20024553L (no) Absorberende gjenstand av ±ngangsbuksetype
DE60139930D1 (de) Desinfizieruns- und desodorierungsverfahren
DE60132108D1 (de) Gefriergetrocknetes pantoprazol-präparat und pantoprazol-injektion
NO20032122L (no) Forbedret behandling
DE60021065D1 (de) Virus behandlung
ATE275938T1 (de) Stabiles und wirksames weiches feststoffprodukt
DE60107990D1 (de) Foliebehandlungsvorrichtung und Umwickelvorrichtung
NO20013337D0 (no) Ny behandling
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DE50111438D1 (de) Matratzenauflagerung
DE60103685D1 (de) Behandlung von Poriomania
PT9812T (pt) Cadeira infantil
DE60139151D1 (de) Haarwuchshemmer und diese enthaltende zusammensetzungen
ATE267598T1 (de) Virus behandlung
NO20023534L (no) Stolunderstell
IT251211Y1 (it) Piedino regolabile per mobili
FR2810862B1 (fr) Ensemble de tables gigognes
FR2797166B1 (fr) Fauteuil reglable
ITMI20000232A0 (it) Poltrone massagianti
SE0000140D0 (sv) Spjälsäng
SE0004887D0 (sv) Massagemadrassen GM 2000
SE0000079D0 (sv) Gardinstång
SE0002674D0 (sv) Barnstol/-säng